Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 0 | |
Hold | 3 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Lyell Immunopharma Inc have a median target of 1.00, with a high estimate of 4.00 and a low estimate of 1.00. The median estimate represents a 9.10% increase from the last price of 0.9166.
High | 336.4% | 4.00 |
Med | 9.1% | 1.00 |
Low | 9.1% | 1.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 03, 2025.
Average growth rate | +2.64% |
Average growth rate | +13.60% |
More ▼
Revenue history & estimates in USD
Average growth rate | +92.49% |
Average growth rate | +297.65% |
More ▼